In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on Elevance Health (ELV – Research Report), with a price ...

In a report released yesterday, Jon Arfstrom from RBC Capital maintained a Hold rating on Discover Financial Services (DFS – Research Report), ...

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $36.02 which represents a slight increase of $1.52 or 4.41% from the prior close of $34.5. The stock opened at $34.25 and touched a low ...

Brokers' investment trust recommendations for 2025 have come later than last year, presumably thanks to the drama currently ...

The luxury rebound is gaining traction, with the latest proof coming from Burberry, where sales outstripped market ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a leading player in the medical devices industry with a market capitalization of $22.08 billion, has been navigating a complex landscape of operational ...

On Thursday, RBC Capital Markets adjusted its outlook on shares ... of Jennifer Piepszak as the new Chief Operating Officer. Barclays (LON:BARC) kept an Overweight rating, highlighting a 1% ...

The Municipal Securities Rulemaking Board Thursday announced the members of its 2025 advisory groups, including those tapped for a new group that will focus on the intersection of technological ...

For 2024, core inflation averaged 2.4%, pulling back sharply from the 4.2% rate seen in 2023. The headline measure came in at 2.7% versus 4.8% in 2023, suggesting that policymakers' efforts to tame ...

The FT said the Treasury had taken the rare step of applying to intervene in an upcoming Supreme Court case, which may lead ...

Less than a day after exiting bullish dollar option trades, some leveraged funds found themselves back in them on Tuesday after US President Donald Trump updated his tariff stance.